polycythemia vera
英
美
网络 多血症; 真性红细胞增多症; 红细胞增多症; 真性多血症; 真性红细胞增多
双语例句
- Extensive thrombosis in portal system with polycythemia vera: one case report
广泛门静脉血栓伴红细胞血红蛋白逐渐增高1例报道 - Clinical Observation of Therapeutic Blood Cell Collection in Treatment of Polycythemia Vera
治疗性血细胞采集术治疗真性红细胞增多症的疗效观察 - Nursing of Hysteromyoma Combined with Polycythemia Vera in Peri-operation
子宫肌瘤合并真性红细胞增多症的围手术期护理 - They had experienced symptoms of polycythemia vera for an average of7 years.
他们平均已患有真性多血症的症状达7年之久。 - Clinical Analysis of Cerebral Venous Sinus Thrombosis Secondary to Polycythemia Vera
真性红细胞增多症继发颅内静脉窦血栓形成两例临床分析 - Objective To study the mechanism, clinical manifestations and pathophysiological characteristics of erythromelalgia accompanying polycythemia vera.
目的研究伴发于真性红细胞增多症的红斑性肢痛症发病机制、临床表现、病理生理特点。 - Cerebral vascular diseases in polycythemia vera patients: A retrospective analysis of 43 cases
真性红细胞增多症并发脑血管病43例临床分析 - Classic MPDs comprise four subtypes: chronic myeloid leukemia ( CML), polycythemia vera ( PV), essential thrombocythemia ( ET) and chronic idiopathic myelofibrosis ( CIMF).
慢性粒细胞白血病（CML）、真性红细胞增多症（PV）、原发性血小板增多症（ET）、慢性特发性骨髓纤维化（CIMF）均归于典型MPD； - Polycythemia vera is a abnormal clone disease of hemopoietic stem cell, of which the characteristics is the increase of Hb and RBC.
真性红细胞增多症（PV）是发生于造血干细胞水平的异常克隆性疾病，以血红蛋白和红细胞数量增高为主要特征。 - Objective: To explore the efficacy of erythrocytapheresis in polycythemia vera ( PV) patients.
目的：探讨红细胞单采术在真性红细胞增多症（PV）治疗中的效果。 - The feature of T cell clonality with polycythemia vera
真性红细胞增多症患者T细胞的克隆特点 - Treatment of polycythemia vera with homoharringtonine: report of 13 cases
高三尖杉酯碱治疗真性红细胞增多症13例报告 - The characteristically analyses of clinical manifestations of ocular disorders as first symptoms for polycythemia vera
以眼部症状为首发表现的真性红细胞增多症患者眼部临床特征分析 - Objective To analyze the particularities of diagnosis and treatment of acute cerebral stroke secondary to polycythemia vera ( PV).
目的分析以脑卒中首发表现的真性红细胞增多症（PV）的诊断和治疗特点。 - Objective: To evaluate the role of Interferon alpha ( IFN-α) in treatment of polycythemia vera ( PV).
目的：探讨干扰素α（IFN-α）治疗真性红细胞增多症（PV）的作用机制。 - Treatment of Polycythemia Vera Chiefly by Activating Blood Circulation and Nourishing Yin: A Clinical Observation of 10 Cases
活血养阴法为主治疗真性红细胞增多症10例临床观察 - Probe in treatment of polycythemia vera ( PV) by the radioactive nuclide~ ( 32) P
放射性核素~（32）P治疗真性红细胞增多症的探讨 - Activating Blood Circulation and Removing Stasis in Treating Polycythemia Vera: Clinical Observation and Therapeutical Mechanism
活（破）血逐瘀法治疗真性红细胞增多症疗效观察及其机理探讨 - Cases of spontaneous subcapsular and perirenal hemorrhage were reviewed. Renal adenoma was found in 4 of them and nephrolithiasis, SLE with nephritis, polycythemia vera, renal tuberculosis, portal hypertension in one each.
近年来诊治自发性肾包膜下和肾周出血患者10例，其中腺癌4例，肾结石、SLE肾炎，真性红细胞增多症、肾结核、门脉高压症及不明原因各1例。 - Erythrocyte Separation Combined with Hydroxyurea and Interferon-α for Treatment of Polycythemia Vera
红细胞去除术联合羟基脲和α-干扰素治疗真性红细胞增多症疗效分析 - Conclusions The skew distribution and clonal expansion of TCR V β subfamily T cells in patients with polycythemia vera might be a feature of the immune response for malignant cells.
结论PV患者外周血TCRVβ亚家族的优势表达和克隆性增殖可能是患者体内对抗恶性细胞的免疫反应特征。 - Objective To analyze and explore the clinical manifestations of ocular disorders for polycythemia vera ( PV).
目的分析和探讨真性红细胞增多症患者眼部病变的临床特征。 - Erythrocytapheresis in combination with drug treatment for polycythemia vera
红细胞单采术联合药物治疗真性红细胞增多症 - Objective To investigate the growth of endogenous erythroid colony ( EEC) in polycythemia vera ( PV) patients and its clinical significance.
目的了解真性红细胞增多症（PV）患者内源性红系集落（EEC）生长情况及其临床意义。 - Expression of apoptosis related proteins in CD34 positive bone marrow cells of patients with polycythemia vera
真性红细胞增多症患者骨髓CD34阳性细胞凋亡相关蛋白的表达 - Diagnosis and Treatment of Polycythemia Vera
真性红细胞增多症的诊断与治疗 - Analysis of the Expression of TCR V β Subfamily T Cells in Patients with Polycythemia Vera by RT-PCR
应用RT-PCR分析真性红细胞增多症病人TCRVβ亚家族T细胞的表达 - To discuss epidermal growth factor receptor inhibitor for the potential targeted therapy of polycythemia vera. Methods: 1.
探讨表皮生长因子受体抑制剂用于真性红细胞增多症靶向治疗的潜能。 - BACKGROUD: Polycythemia vera ( PV) is a malignant clonal hemotopoietic disorder resulted from the mutation of multipotent hematopoietic stem cells.
〖研究背景〗真性红细胞增多症（PV）是由于多潜能造血干细胞发生突变而引起的恶性克隆性疾病。 - Polycythemia Vera ( PV) is a clonal stem cell disease with yet unknown pathogenesis.
真性红细胞增多症（真红）系克隆性造血干细胞疾病，病因和发病机理不明。